Literature DB >> 8132764

Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty.

A E Villa1, L A Guzman, W Chen, G Golomb, R J Levy, E J Topol.   

Abstract

A periadventitial polymer system is an alternative local drug delivery technique to obtain and maintain high tissue levels of the drug at the site of vascular injury. To determine if local periadventitial delivery of dexamethasone decreases neointimal proliferation after balloon vascular injury, in three groups of Sprague-Dawley rats, 5% dexamethasone, 0.5% dexamethasone, and placebo silicone polymers were implanted around the left common carotid artery after balloon injury. In a fourth group, placebo polymers were implanted without balloon injury. Dexamethasone serum and tissue levels after polymer implantation were significantly higher in the 5% dexamethasone group compared with the 0.5% dexamethasone group. There was no neointima formation in any of the arterial segments covered with placebo polymers for 3 wk, but without balloon injury. In the arterial segments covered by the 5 and 0.5% dexamethasone polymers, there was a 76 and 75% reduction in intima/media ratios, respectively, compared with the placebo group (5% dexamethasone, 0.26 +/- 0.04; 0.5% dexamethasone, 0.27 +/- 0.03; placebo, 1.09 +/- 0.16, respectively; P < 0.0001). These results suggest that: (a) silicone polymers wrapped around the common carotid arteries for 3 wk did not, without balloon injury, stimulate neointimal proliferation in the rat model; (b) the activity of the drug-eluting polymer for suppressing intimal proliferation was chiefly, but not exclusively, site specific; and (c) transadventitial local delivery of dexamethasone at two different doses markedly inhibits neointimal proliferation after balloon vascular injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132764      PMCID: PMC294076          DOI: 10.1172/JCI117078

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.

Authors:  J S Powell; J P Clozel; R K Müller; H Kuhn; F Hefti; M Hosang; H R Baumgartner
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

2.  Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery.

Authors:  H Wolinsky; S N Thung
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

3.  Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation.

Authors:  T Okada; D H Bark; M R Mayberg
Journal:  Neurosurgery       Date:  1989-12       Impact factor: 4.654

4.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

Authors:  E W Raines; S K Dower; R Ross
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

5.  The porous titanium steroid eluting electrode: a double blind study assessing the stimulation threshold effects of steroid.

Authors:  H Mond; K Stokes; J Helland; L Grigg; P Kertes; B Pate; D Hunt
Journal:  Pacing Clin Electrophysiol       Date:  1988-02       Impact factor: 1.976

Review 6.  Fos and Jun: the AP-1 connection.

Authors:  T Curran; B R Franza
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

7.  The collagenase gene family in humans consists of at least four members.

Authors:  D Muller; B Quantin; M C Gesnel; R Millon-Collard; J Abecassis; R Breathnach
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

8.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

Authors:  S W Lee; A P Tsou; H Chan; J Thomas; K Petrie; E M Eugui; A C Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Local anticoagulation without systemic effect using a polymer heparin delivery system.

Authors:  T Okada; D H Bark; M R Mayberg
Journal:  Stroke       Date:  1988-12       Impact factor: 7.914

10.  Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.

Authors:  S G Ellis; G S Roubin; J Wilentz; J S Douglas; S B King
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

View more
  18 in total

1.  Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.

Authors:  George Michas; Marcel Liberman; Kristian C Becker; Diane E Handy; Joseph Loscalzo; Jane A Leopold
Journal:  Mol Cell Biochem       Date:  2010-10-05       Impact factor: 3.396

2.  Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo.

Authors:  H Ooboshi; C D Ríos; D D Heistad
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

3.  Glucocorticoid treatment and cardiovascular disease.

Authors:  M K C Ng; D S Celermajer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 4.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

5.  Iontophoresis for modulation of cardiac drug delivery in dogs.

Authors:  V Labhasetwar; T Underwood; S P Schwendeman; R J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome.

Authors:  C Kristo; T Ueland; K Godang; P Aukrust; J Bollerslev
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

7.  Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Authors:  P C Souverein; A Berard; T P Van Staa; C Cooper; A C G Egberts; H G M Leufkens; B R Walker
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats.

Authors:  Emilio A Herrera; Misha M Verkerk; Jan B Derks; Dino A Giussani
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

9.  Alagebrium chloride, a novel advanced glycation end-product cross linkage breaker, inhibits neointimal proliferation in a diabetic rat carotid balloon injury model.

Authors:  Jin-Bae Kim; Byeong-Wook Song; Sungha Park; Ki-Chul Hwang; Bong-Soo Cha; Yangsoo Jang; Hyun-Chul Lee; Moon-Hyoung Lee
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

10.  Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis.

Authors:  Laura J Janke; Chengcheng Liu; Peter Vogel; Jitesh Kawedia; Kelli L Boyd; Amy J Funk; Mary V Relling
Journal:  Am J Pathol       Date:  2013-05-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.